CompanyIGCNYSEPotomac, MD

IGC Pharma, LLC

IGC Pharma develops small-molecule therapies for Alzheimer's disease.

10-QAug 14Latest SEC filing, period to Jun 30

Jul 13Latest story

July 2026

Jul 13Clinical readoutIGC Pharma, LLC

Jul 6PartnershipIGC Pharma, LLC